Robotics Stock news
Intuitive Surgical (NASDAQ: ISRG) announced on September 11, 2026, that it has received FDA 510(k) clearance for its next--generation "Ion" endoluminal system enhancement, the "Digital Vision Suite."
Key strategic highlights include:
- Technological Advancement: The suite integrates AI--driven real--time tomosynthesis, allowing for higher precision and improved diagnostic yields during peripheral lung biopsies.
- Market Expansion: This clearance enables the company to target a broader range of complex diagnostic procedures, strengthening its competitive position in the minimally invasive medical robotics sector.
- Commercial Rollout: A phased commercial launch is scheduled to begin in the United States in mid--October 2026, with international regulatory filings expected to follow in early 2027.